THE FIRESTORM OF US DRUG TRENDS
Course Overview

Consultant: Merrill Norton

About: This talk is to assist professionals in helping America overcome the firestorm of the top 10 drug trends in the US. Based on a public health model, three types of strategies to prevent drug use can be discerned: primary, secondary and tertiary prevention. Primary prevention programs (anticipation and prevention of the occurrence of drug abuse) have mostly been directed to elementary grade school children in general. Secondary prevention (aiming at the discontinuation of infrequent drug-use) the stage (or stepping-stone) shifts from sociocultural influences to the individual at risk for a substance use disorder. Tertiary prevention (preventing the retaking of substances after achieving abstinence), research evaluating programs for prevention of abuse of alcohol and other drugs indicates a limited staying power. Professionals can provide all three types of prevention to their communities with the proper training and desire

Learning Objectives:

  1. Learn the focus areas of substance use disorders in the US.
  2. Effective prevention strategies to combat the substance use .
  3. Gain an understanding of the top 10 drug trends in the  US, including fentanyl, nitazenes, xylazine, kratom and others.
Summary
Availability:
On-Demand
Expires on Jun 16, 2029
Cost:
FREE
Credit Offered:
1 Attendance Credit
 
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.



Funding for this initiative was made possible (in part) by grant no. 1H79TI088037 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

The development of this educational resource (in part) was originally funded by the Substance Abuse and Mental Health Services Administration’s (SAMHSA’s) Providers Clinical Support System-Medications for Opioid Used Disorder (PCSS-MOUD), cooperative agreement no. 1H79TI086770, with the American Academy of Addiction Psychiatry (AAAP), ending September 29, 2026.

 
American Academy of Addiction Psychiatry
www.aaap.org
Contact Us

Opioid Response Network
opioidresponsenetwork.org

Powered By